BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12572074)

  • 1. [Improvement of amplification method for Cryptosporidium parvum oocysts from mice].
    Huang KH; Yang SG; Tang JX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(6):360-2. PubMed ID: 12572074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on methods for isolation and purification of Cryptosporidium parvum oocysts from mouse feces].
    Chen F; Huang KH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Jun; 24(3):219-22. PubMed ID: 17094628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice.
    Yang S; Healey MC; Du C
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):141-5. PubMed ID: 8731022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectivity of Cryptosporidium parvum oocysts following cryopreservation.
    Kim HC; Healey MC
    J Parasitol; 2001 Oct; 87(5):1191-4. PubMed ID: 11695396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified methods for obtaining purified oocysts from mice and for growing Cryptosporidium parvum in vitro.
    Meloni BP; Thompson RC
    J Parasitol; 1996 Oct; 82(5):757-62. PubMed ID: 8885885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent gut infections in immunosuppressed adult C57BL/6N mice following intraperitoneal injection of Cryptosporidium parvum oocysts.
    Yang S; Healey MC
    J Parasitol; 1994 Apr; 80(2):338-42. PubMed ID: 8158484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive effects of dexamethasone administered in drinking water to C57BL/6N mice infected with Cryptosporidium parvum.
    Yang S; Healey MC
    J Parasitol; 1993 Aug; 79(4):626-30. PubMed ID: 8331488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo.
    Huang K; Yang S
    Biol Trace Elem Res; 2002; 90(1-3):261-72. PubMed ID: 12666840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.
    Hikosaka K; Satoh M; Koyama Y; Nakai Y
    Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Cryptosporidium parvum oocyst propagation using dexamethasone suppressed CF-1 mice.
    Ware MW; Villegas EN
    Vet Parasitol; 2010 Mar; 168(3-4):329-31. PubMed ID: 20036060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A NMRI suckling mouse model for the evaluation of infectivity of Cryptosporidium parvum oocysts.
    Xunde LI; Brasseur P
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(2):94-6. PubMed ID: 12567724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
    Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of most probable number-PCR and most probable number-foci detection method for quantifying infectious Cryptosporidium parvum oocysts in environmental samples.
    Carey CM; Lee H; Trevors JT
    J Microbiol Methods; 2006 Nov; 67(2):363-72. PubMed ID: 16730821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in Cryptosporidium parvum oocyst infectivity in vitro by using the membrane filter dissolution method for recovering oocysts from water samples.
    Carreno RA; Pokorny NJ; Weir SC; Lee H; Trevors JT
    Appl Environ Microbiol; 2001 Jul; 67(7):3309-13. PubMed ID: 11425759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Die-off of Cryptosporidium parvum in soil and wastewater effluents.
    Nasser AM; Tweto E; Nitzan Y
    J Appl Microbiol; 2007 Jan; 102(1):169-76. PubMed ID: 17184332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative comparison of density-based purification methods for detection of Cryptosporidium oocysts in turbid environmental matrices.
    Chesnot T; Schwartzbrod J
    J Microbiol Methods; 2004 Sep; 58(3):375-86. PubMed ID: 15279942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptosporidium parvum oocysts recovered from water by the membrane filter dissolution method retain their infectivity.
    Graczyk TK; Fayer R; Cranfield MR; Owens R
    J Parasitol; 1997 Feb; 83(1):111-4. PubMed ID: 9057705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-yield amplification of Cryptosporidium parvum in interferon gamma receptor knockout mice.
    von Oettingen J; Nath-Chowdhury M; Ward BJ; Rodloff AC; Arrowood MJ; Ndao M
    Parasitology; 2008 Sep; 135(10):1151-6. PubMed ID: 18667105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C
    J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.